Nurx Review: $79 a Month Before You Buy Any Medication

For the care, $79 once and then $79 every month, neither of which is billed to insurance. For the medication, it depends entirely on which route you land on. A Zepbound single-dose vial is $349 a month at the starting dose and $499 at 5 mg, delivered by Gifthealth — so $578 a month all-in once you add the support fee. A branded pen is a different world: Nurx puts Wegovy at "$1300/month on average for the lowest dose" and Zepbound and Ozempic pens at $1,000, collected and paid for at your local pharmacy, so $1,379 all-in for Wegovy. Oral medication is the cheap end, $15 to $105 a month depending on what you are prescribed. Read off nurx.com on August 9, 2026.

Because Nurx says it is not, in its own cost FAQ: "The medical consult fee is a one time charge of $79. Patients will also be charged an ongoing care fee of $79/month." What the monthly fee covers, in Nurx's words, is "a Nurx provider managing your medication needs" plus unlimited messaging with the medical team. For branded GLP-1 pens it does not even cover getting the drug to you — Nurx states that "this medication is not available for home delivery through Nurx" and that "you will pick up and pay for your medication at your local pharmacy". So on the most expensive route Nurx sells, you are paying $79 a month for a prescriber and an inbox.

Because Nurx is quoting a retail pharmacy counter rather than the manufacturer. Its Wegovy page says "Starts at $1300 for a 1-month supply" and adds "on average for lowest dose without insurance coverage (ask your local pharmacy to confirm the price)". What it never says — and this was tested rather than assumed, across all 606 pages of the site — is that the words NovoCare and LillyDirect appear on the site zero times. Novo Nordisk operates a self-pay pharmacy that sells Wegovy directly to cash patients for a fraction of $1,300, and Eli Lilly does the same for Zepbound. Nurx's own Zepbound vial route goes through Lilly's fulfilment partner, so the company clearly knows these channels exist. A patient reading its Wegovy page would not.

The Zepbound single-dose vial, at $349 a month for the starting 2.5 mg dose and $499 at 5 mg, delivered by Gifthealth rather than collected. That is a genuinely competitive number and it is properly documented — the 45-day refill condition, the higher standard prices of $599 and $699 if you miss it, and the separate charge for injection supplies are all disclosed. The problem is where they are disclosed. The entire ladder appears on one page of the site, /weight-management/orals-compounded/, whose heading is "Nurx 3-in-1 Pill". Nurx's actual Zepbound page never mentions a vial and prices only the pen at $1,000. If you go looking for tirzepatide the way a reader naturally would, you will pay nearly three times what Nurx can actually get it for.

Nurx does not say, and both pages are live. Its general weight-management page and its cost FAQ both give the same figures: $79 for the consultation, $79 a month afterwards. The page titled "Weight management for men" says "TThe medical consult fee is a one time charge of $39. Patients will also be charged a monthly provider support fee of $59/month" — the doubled T is on Nurx's page, not a transcription error here. The clinical eligibility copy, the drug list and the disclaimers on the two pages are otherwise identical. This review uses $79 and $79, because that is what the cost FAQ and all six brand pages say; if you are quoted more than $59 a month, the men's page is worth having open.

On the vial route, $79 for the consultation plus twelve months at $578 is $7,015 at a 5 mg maintenance dose — and $8,215 if your refills slip past the 45-day window and you land on the $599 tier at 7.5 mg. On the pen route it is $79 plus twelve at $1,379, or $16,627. That gap is the whole review: two ways to buy tirzepatide through the same company, roughly $9,000 apart, and only one of them documented on the page about the drug. Oral medication is a different order of magnitude again — $79 plus twelve months of $79 support and $60 of pills is about $1,747.

No, though its site still describes two. Live drug-facts sheets exist for a "Nurx Custom GLP-1 Injection Formula: Semaglutide (5mg or 7.5mg) and Glycine (5mg)" and a "Nurx GLP-1 Pill: Semaglutide/B6/B12". Neither is buyable: neither appears in Nurx's product sitemap, neither is priced anywhere on the site, and of the 606 pages crawled the only two that link to those URLs are the pages themselves. They are orphaned leftovers from the shortage era. A compounded semaglutide would be the cheapest row on this review by a wide margin, and it is not on offer. What Nurx does compound is a three-in-one weight-loss pill — naltrexone with bupropion and either metformin or topiramate — from $75 a month, and it labels it accurately: "Compounded drugs are not FDA-approved or evaluated for safety, efficacy, or quality."

There is no way to find out without starting the intake, and Nurx has told you the question matters. The footnote on its homepage, its services page and every weight-management page reads "Services and treatments not offered in every state", and the Terms add that "the Service may not be available in your state". All 606 pages of the site were searched and not one names an excluded state. The dropdown at the first step of the funnel is not an answer either — it lists Guam, Palau, the Marshall Islands and the Armed Forces codes, which is a stock US territory control rather than a coverage list. A company that publishes a warning about state gaps and then publishes no list has done the harder half and skipped the useful half.

No. The live warning-letter index was queried on August 9, 2026 as "nurx" (0 results), "nurx pharmacy" (0), and "thirty madison" (0) — that last being the corporate parent Nurx names in the first paragraph of its own Terms. The pharmacy on its vial page was screened too: "gifthealth" (0) and "gift health" (5). Broad forms "madison" (8) and "nur" (25) were run to catch spacing variants. Every query returned its full result set with no truncation, and every row was re-matched against the company column: not one contains nurx, madison or gift. Nothing is filed on a resemblance. A positive control returned SkinnyRx's February 2026 letter in the same pass, so the absence is a result rather than a broken query.

You can cancel — the Terms say a subscription "is continuous and will be automatically renewed" unless you cancel before the period ends, and that cancelling closes the account at the end of the current billing period. What you will not get is a refund. The only money-back promise in the whole document is a "100% Satisfaction Guarantee" attached to the Nurx menopause programme, and it does not extend to weight management. The $79 consultation fee is gone the moment you request treatment, prescribed or not. And the Terms allow Nurx to "change the price for any subscriptions, from time to time", with changes taking effect at the start of the next subscription period.